Last reviewed · How we verify

NCT05552170

Evaluation of Short-term Outcomes of Ambulatory Loop Ileostomy Reversal

Status unknown Last updated 23 September 2022
What this trial tests

trial testing day-case surgery in Surgery in 216 participants. Status unknown.

Timeline
1 August 2017
Primary endpoint
31 July 2025
31 August 2025

Quick facts

Lead sponsorWest China Hospital
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment216
Start date1 August 2017
Primary completion31 July 2025
Estimated completion31 August 2025
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

West China Hospital

Who can join

Adults 18 to 65, any sex, with Surgery or Fast Recovery Surgery. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Based on enhanced recovery after surgery (ERAS), ambulatory loop ileostomy reversal (ALIR) has been reported in developed countries. However, there is still no research proposing how to carry out ALIR in developing countries. This study was performed to determine the feasibility of ALIR in China based on the community hospital joined enhanced recovery after surgery (CHJ-ERAS) program.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Surgery

Currently open trials in the same condition.

Other West China Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05552170.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing